Physician profile
Roy D Vingan
NPI 1356318950
$23,702.69
in general payments reported to CMS, 2019-2025
21 companies · $8,491 in 2025
The $8,491 reported for 2025 was more than what 84% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,646 · 2020: $3,459 · 2021: $84.75 · 2022: $187 · 2023: $1,755 · 2024: $4,079 · 2025: $8,491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,075 · Travel and Lodging: $3,065 · Food and Beverage: $2,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,075.00 |
| Travel and Lodging | $3,065.42 |
| Food and Beverage | $2,185.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $11,561.64 | 2020-2025 | Mars, Xlif, Excelsius Gps |
| Nuvasive, INC. | $6,589.37 | 2019-2020 | |
| Alphatec Spine, INC | $2,475.30 | 2023-2025 | Other - Miscellaneous, Amp |
| Medtronic USA, INC. | $639.35 | 2020 | |
| Providence Medical Technology, INC. | $425.07 | 2025 | |
| Augmedics INC. | $318.93 | 2024-2025 | Xvision |
| Surgalign Spine Technologies, INC. | $266.26 | 2019-2020 | |
| Stryker Corporation | $254.86 | 2019-2020 | |
| Arteriocyte Medical Systems, INC. | $234.10 | 2020 | |
| Depuy Synthes Sales INC. | $197.20 | 2021-2022 | |
| Xtant Medical INC | $121.07 | 2023 | |
| Vb Spine LLC | $120.69 | 2025 | Prolift |
| Bioventus LLC | $109.45 | 2019 | |
| Innovation Technologies INC | $82.81 | 2020 | |
| Trackx Technology, INC. | $82.13 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $69.61 | 2022 | |
| Davol INC. | $53.17 | 2025 | Channel Drain |
| Kerecis Limited | $46.07 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ossdsign USA Incorporated | $30.94 | 2025 | Ossdsign Catalyst |
| Biotronik Nro, INC. | $19.60 | 2025 | Prospera |
| Spinal Elements, INC. | $5.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Vingan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.